Ebstein malformation of the tricuspid valve

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1880OMIM:224700Q22.5
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ebstein malformation of the tricuspid valve (also known as Ebstein anomaly or Ebstein's anomaly) is a rare congenital heart defect in which the tricuspid valve — the valve separating the right atrium from the right ventricle — is abnormally formed and displaced downward into the right ventricle. This displacement causes a portion of the right ventricle to become 'atrialized' (functionally part of the atrium), resulting in a smaller, less effective right ventricle and varying degrees of tricuspid valve regurgitation (leaking). The condition primarily affects the cardiovascular system and can be associated with an atrial septal defect or patent foramen ovale, which may allow right-to-left shunting of blood and lead to cyanosis (bluish discoloration of the skin due to low oxygen levels). The clinical presentation of Ebstein anomaly is highly variable, ranging from severe heart failure in neonates to mild symptoms discovered incidentally in adulthood. Key symptoms may include cyanosis, fatigue, exercise intolerance, shortness of breath, palpitations, and signs of right-sided heart failure such as peripheral edema and hepatomegaly. Cardiac arrhythmias are common, particularly supraventricular tachycardias, and some patients have accessory conduction pathways (Wolff-Parkinson-White syndrome). The condition is also associated with other congenital heart defects, including pulmonary stenosis or atresia. Management depends on the severity of the malformation. Mildly affected individuals may require only monitoring and medical management of arrhythmias and heart failure symptoms. More severely affected patients may require surgical intervention, including tricuspid valve repair (such as the cone reconstruction technique), tricuspid valve replacement, closure of atrial septal defects, or catheter ablation for arrhythmias. In the most severe neonatal cases, complex surgical strategies or even heart transplantation may be considered. Prognosis varies widely based on the degree of valve displacement and associated anomalies, but advances in surgical techniques have significantly improved outcomes for many patients.

Also known as:

Clinical phenotype terms— hover any for plain English:

Ebstein anomaly of the tricuspid valveHP:0010316Imperforate tricuspid valveHP:0011575Atrial fibrillationHP:0005110Complete right bundle branch blockHP:0011712Holosystolic murmurHP:0031667
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ebstein malformation of the tricuspid valve.

View clinical trials →

No actively recruiting trials found for Ebstein malformation of the tricuspid valve at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ebstein malformation of the tricuspid valve community →

Specialists

2 foundView all specialists →
MM
Muhammad Y Qureshi, MBBS
Specialist
PI on 2 active trials
CA
Christine H Attenhofer
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ebstein malformation of the tricuspid valve.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ebstein malformation of the tricuspid valveForum →

No community posts yet. Be the first to share your experience with Ebstein malformation of the tricuspid valve.

Start the conversation →

Latest news about Ebstein malformation of the tricuspid valve

No recent news articles for Ebstein malformation of the tricuspid valve.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ebstein malformation of the tricuspid valve

What is Ebstein malformation of the tricuspid valve?

Ebstein malformation of the tricuspid valve (also known as Ebstein anomaly or Ebstein's anomaly) is a rare congenital heart defect in which the tricuspid valve — the valve separating the right atrium from the right ventricle — is abnormally formed and displaced downward into the right ventricle. This displacement causes a portion of the right ventricle to become 'atrialized' (functionally part of the atrium), resulting in a smaller, less effective right ventricle and varying degrees of tricuspid valve regurgitation (leaking). The condition primarily affects the cardiovascular system and can be

Which specialists treat Ebstein malformation of the tricuspid valve?

2 specialists and care centers treating Ebstein malformation of the tricuspid valve are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.